
Cervical Dysplasia Market Share, Size, Trends, Industry Analysis Report, By Type (Diagnostic Tests, {HPV Test, Pap Smear Test, Biopsy Test}, Diagnostic Devices, Colposcope); By End-Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), By Regio
Description
The global cervical dysplasia market size is expected to reach USD 1,747.17 million by 2034 according to a new study by Polaris Market Research. The report “Cervical Dysplasia Market Share, Size, Trends, Industry Analysis Report, By Type (Diagnostic Tests, {HPV Test, Pap Smear Test, Biopsy Test}, Diagnostic Devices, Colposcope); By End-Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), By Regions; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising prevalence of cervical cancer and awareness regarding its early diagnosis is the key cervical dysplasia industry impacting factors. As per the report published by World Health Organization, in 2018, worldwide there were around 5, 70,000 new cases of cervical cancer, and more than 3,11,000 deaths were recorded. It also reported that HPV is the most common causal factor for cervical dysplasia among women.
Moreover, Cervical Awareness Month was introduced by the U.S. Congress, in 2019, to declare the month of January dedicated to the patients suffering from cervical cancer in the market. National Cervical Cancer Coalition under government control was responsible to highlight issues related to disease and the importance of early diagnosis. These government-supported initiatives are bound to increase awareness regarding disease screening and are anticipated to boost the market growth for cervical dysplasia.
Market participants such as Qiagen N.V., Abbott Laboratories, Hologic, Inc., Quest Diagnostics, DYSIS Medical Ltd, Micromedic Technologies Ltd., OncoHealth Corporation, Inc., CooperSurgical Inc., and Roche are some of the key players operating in the global market for cervical dysplasia. The companies in the marketplace for cervical dysplasia are focussing on collaborations and agreement to survive in the highly regulated market with huge patient unmet needs.
For instance, in January 2020, both Japan pharmaceutical giants ASKA Pharmaceutical and KinoPharma entered into a collaborative agreement for the development and commercialization of drug candidates for cervical dysplasia in the market, which is under preclinical phase under KinoPharma. Under the agreement, ASKA would obtain exclusive rights to sell the drug in the Japanese market and will help later in co-developing potential drug candidates and KinoPharma in return will receive upfront payments for the exclusive licensing.
Polaris Market research has segmented the cervical dysplasia market report on the basis of type, end-use, and region:
Cervical Dysplasia, by Type Outlook (Revenue - USD Million, 2020 – 2034)
Diagnostic Tests
HPV Test
Pap Smear Test
Biopsy Test
Diagnostic Devices
Colposcope
Cervical Dysplasia, by End-Use Outlook (Revenue - USD Million, 2020 – 2034)
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Cervical Dysplasia, by Regional Outlook (Revenue - USD Million, 2020 – 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Central & South America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The rising prevalence of cervical cancer and awareness regarding its early diagnosis is the key cervical dysplasia industry impacting factors. As per the report published by World Health Organization, in 2018, worldwide there were around 5, 70,000 new cases of cervical cancer, and more than 3,11,000 deaths were recorded. It also reported that HPV is the most common causal factor for cervical dysplasia among women.
Moreover, Cervical Awareness Month was introduced by the U.S. Congress, in 2019, to declare the month of January dedicated to the patients suffering from cervical cancer in the market. National Cervical Cancer Coalition under government control was responsible to highlight issues related to disease and the importance of early diagnosis. These government-supported initiatives are bound to increase awareness regarding disease screening and are anticipated to boost the market growth for cervical dysplasia.
Market participants such as Qiagen N.V., Abbott Laboratories, Hologic, Inc., Quest Diagnostics, DYSIS Medical Ltd, Micromedic Technologies Ltd., OncoHealth Corporation, Inc., CooperSurgical Inc., and Roche are some of the key players operating in the global market for cervical dysplasia. The companies in the marketplace for cervical dysplasia are focussing on collaborations and agreement to survive in the highly regulated market with huge patient unmet needs.
For instance, in January 2020, both Japan pharmaceutical giants ASKA Pharmaceutical and KinoPharma entered into a collaborative agreement for the development and commercialization of drug candidates for cervical dysplasia in the market, which is under preclinical phase under KinoPharma. Under the agreement, ASKA would obtain exclusive rights to sell the drug in the Japanese market and will help later in co-developing potential drug candidates and KinoPharma in return will receive upfront payments for the exclusive licensing.
Polaris Market research has segmented the cervical dysplasia market report on the basis of type, end-use, and region:
Cervical Dysplasia, by Type Outlook (Revenue - USD Million, 2020 – 2034)
Diagnostic Tests
HPV Test
Pap Smear Test
Biopsy Test
Diagnostic Devices
Colposcope
Cervical Dysplasia, by End-Use Outlook (Revenue - USD Million, 2020 – 2034)
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Cervical Dysplasia, by Regional Outlook (Revenue - USD Million, 2020 – 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Central & South America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
108 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Japan Ophthalmic Spectacle Lenses and Equipment Market Insights
- 4.1. Ophthalmic Spectacle Lenses and Equipment Market – Usage Snapshot
- 4.2. Ophthalmic Spectacle Lenses and Equipment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise of Remote Work and Digital Learning Platform
- 4.2.1.2. Ageing Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Ophthalmic Spectacle Lenses and Equipment Market Usage Trends
- 4.6. Value Chain Analysis
- 5. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Product, 2020-2034 (USD Billion)
- 5.3. Ophthalmic Spectacle Lenses
- 5.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Ophthalmic Spectacle Lenses, by Region, 2020-2034 (USD Billion)
- 5.4. Ophthalmic Spectacle Equipment
- 5.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Ophthalmic Spectacle Equipment, by Region, 2020-2034 (USD Billion)
- 6. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Lens Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Lens Type, 2020-2034 (USD Billion)
- 6.3. Single-Vision Lens
- 6.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Single-Vision Lens, by Region, 2020-2034 (USD Billion)
- 6.4. Multifocal Lenses
- 6.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Multifocal Lenses, by Region, 2020-2034 (USD Billion)
- 6.4.2. Progressive Lenses
- 6.4.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Progressive Lenses, by Region, 2020-2034 (USD Billion)
- 6.4.3. Bifocal Lenses
- 6.4.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Bifocal Lenses, by Region, 2020-2034 (USD Billion)
- 6.4.4. Trifocal Lenses
- 6.4.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Trifocal Lenses, by Region, 2020-2034 (USD Billion)
- 6.5. Other
- 6.5.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Other, by Region, 2020-2034 (USD Billion)
- 7. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Lens Material
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Lens Material, 2020-2034 (USD Billion)
- 7.3. Plastic
- 7.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Plastic, by Region, 2020-2034 (USD Billion)
- 7.3.2. Polycarbonate
- 7.3.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Polycarbonate, by Region, 2020-2034 (USD Billion)
- 7.3.3. Polycarbonate
- 7.3.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Polycarbonate, by Region, 2020-2034 (USD Billion)
- 7.3.4. CR-39 Plastic
- 7.3.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by CR-39 Plastic, by Region, 2020-2034 (USD Billion)
- 7.3.5. Others
- 7.3.5.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Others, by Region, 2020-2034 (USD Billion)
- 7.4. Glass
- 7.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Glass, by Region, 2020-2034 (USD Billion)
- 8. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Usage
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Usage, 2020-2034 (USD Billion)
- 8.3. Prescription Spectacle Lenses
- 8.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Prescription Spectacle Lenses, by Region, 2020-2034 (USD Billion)
- 8.4. Non-prescription Spectacle Lenses
- 8.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Non-prescription Spectacle Lenses, by Region, 2020-2034 (USD Billion)
- 9. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Equipment
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Equipment, 2020-2034 (USD Billion)
- 9.3. Lens Fabrication Equipment
- 9.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Lens Fabrication Equipment, by Region, 2020-2034 (USD Billion)
- 9.3.2. Lens Generators
- 9.3.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Lens Generators, by Region, 2020-2034 (USD Billion)
- 9.3.3. Edging Machines
- 9.3.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Edging Machines, by Region, 2020-2034 (USD Billion)
- 9.3.4. Others
- 9.3.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Others, by Region, 2020-2034 (USD Billion)
- 9.4. Lens Coating Equipment
- 9.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Media & Entertainment, by Region, 2020-2034 (USD Billion)
- 9.4.2. Anti-Reflective Coating Machines
- 9.4.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Anti-Reflective Coating Machines, by Region, 2020-2034 (USD Billion)
- 9.4.3. Hard Coating Equipment
- 9.4.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Hard Coating Equipment, by Region, 2020-2034 (USD Billion)
- 9.4.4. UV Coating Equipment
- 9.4.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by UV Coating Equipment, by Region, 2020-2034 (USD Billion)
- 9.4.5. Others
- 9.4.5.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Others, by Region, 2020-2034 (USD Billion)
- 9.5. Optical Measurement Equipment
- 9.5.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Optical Measurement Equipment, by Region, 2020-2034 (USD Billion)
- 9.5.2. Refractors & Autorefractors
- 9.5.2.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Refractors & Autorefractors, by Region, 2020-2034 (USD Billion)
- 9.5.3. Lensometer
- 9.5.3.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Lensometer, by Region, 2020-2034 (USD Billion)
- 9.5.4. Others
- 9.5.4.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Others, by Region, 2020-2034 (USD Billion)
- 9.6. Other
- 9.6.1. Japan Ophthalmic Spectacle Lenses and Equipment Market, by Other, by Region, 2020-2034 (USD Billion)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. Bausch + Lom
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. EssilorLuxottica
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. GKB Ophthalmics Ltd.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Hoya Corporation
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Johnson & Johnson
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Nikon Corporation
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Rodenstock GmbH
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Vision Service Plan (VSP) Global
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Zeiss Vision Care
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. TOKAI OPTICAL Co., Ltd
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.